People | April 15, 2026
Biocon appoints Karthik SM as Head HR for India, Malaysia and Emerging Markets
In his new role, Karthik will lead human capital strategy and HR operations across these regions
In his new role, Karthik will lead human capital strategy and HR operations across these regions
The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
The centre offers a full spectrum of FDA-approved services, including physiotherapy, occupational therapy, speech and language therapy, and aqua therapy
The license is valid for five years, effective from April 9, 2026
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
